Why Health In Tech, Inc.’s (HIT) Stock Is Up 6.66%
As of Tuesday, July 07, Health In Tech, Inc.’s HIT share price has surged by 6.66%, which has investors questioning if this is right time to sell.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Health In Tech, Inc. operates as an insurance technology platform company in the United States. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; SMR, a program manager specializing in customized self-funded benefits plans for businesses; ICE is, an MGU, which specializes in underwriting and providing administrative functions on behalf of stop loss carriers; and enhance do it yourself benefit system (eDIYBS), a web-based SaaS quoting platform to quote health insurance for small and medium sized employers. It also provides health intelligence (HI) cards to streamline the management of medical records and claims; and HI performance network, which offers a series of hospital facilities, as well as delivers medicare-based reimbursement pricing. Health In Tech, Inc. was founded in 2014 and is headquartered in Stuart, Florida.
Commentary & Analysis
Why Health In Tech, Inc.’s (HIT) Stock Is Down 5.77%
As of Monday, June 29, Health In Tech, Inc.’s HIT share price has dipped by 5.77%, which has investors questioning if this is right time to buy.Michael Rose
Why Health In Tech, Inc.’s (HIT) Stock Is Down 6.07%
As of Friday, June 26, Health In Tech, Inc.’s HIT share price has dipped by 6.07%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Health In Tech, Inc.’s (HIT) Stock Is Down 5.56%
As of Monday, June 22, Health In Tech, Inc.’s HIT share price has dipped by 5.56%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Health In Tech, Inc.’s (HIT) Stock Is Up 6.22%
As of Thursday, June 04, Health In Tech, Inc.’s HIT share price has surged by 6.22%, which has investors questioning if this is right time to sell.Jenna Brashear
Financial Summary
| Share Statistics | HIT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $72.8 | $7,055.8 | 19% |
|
| Shares Out (Mil) | 57.4 | 66.0 | 51% |
|
| Institutional Ownership | 5.4% | 81.8% | 5% |
|
| Float (Mil) | 20.2 | 67.4 | 29% |
|
| Beta | na | 0.52 | na |
|
| Avg Daily Volume (000s) | 46 | 186 | 27% |
|
| Price Change (52-week) |
(33.1%) | 90.4% | 23% |
|
| Growth | HIT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 5.6% | na |
|
| Net Income (5yr) | na | 14.5% | na |
|
| EPS (5yr) | na | 15.6% | na |
|
| Dividends (5yr) | na | 3.8% | 0% |
|
| Cash Flow (5yr) | na | (14.5%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | ($0.027) | ($0.057) | $0.143 | |
| Month Ago EPS | ($0.027) | ($0.057) | $0.143 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.020) | ($0.010) | $0.163 | |
| Year/Year Chg | (10.0%) | (385.0%) | na | |
| Financials | HIT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $34 | $5,065 | 17% |
|
| Net Income (TTM) (Mil) | ($1) | $534 | 38% |
|
| EPS (TTM) | ($0.014) | $2.500 | 39% |
|
| Operating Cash Flow (TTM) (Mil) | ($1) | $499 | 31% |
|
| Net Cash Flow (TTM) (Mil) | $3 | $3 | 50% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $844 | 0% |
|
| Enterprise Value (Q1) (Mil) | $60 | $7,585 | 17% |
|
| Valuation | HIT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.36 | 1.77 | 68% |
|
| P/E | na | 12.9 | na |
|
| Dividend Yield | 0.0% | 0.9% | 0% |
|
| PEG (5yr hist) | na | 0.5 | na |
|
| Ratios | HIT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 58.9% | 33.4% | 72% |
|
| Net Margin | (2.4%) | 9.9% | 28% |
|
| ROA | (3.2%) | 2.7% | 32% |
|
| ROE | (4.5%) | 14.8% | 31% |
|
| Liabilities to Assets | 25.4% | 76.7% | 17% |
|
| F-Score | 3 | 6 | 19% |
|
Health In Tech, Inc. did not pass any screens on 7/31/2026.
